|
⚲
|
| Keyboard |
| David Esposito | |
|---|---|
| Firm | |
| Address | 524 S Main St Suite 110 Ann Arbor, MI 48104 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| ONL Therapeutics Inc | 021-524116 | Executive Officer | 60.0 M of 65.0 M |
||
| ONL Therapeutics Inc | 021-507285 | Executive Officer | 10.0 M of 10.0 M |
||
| ONL Therapeutics Inc | 021-475907 | Executive Officer | 5.0 M of 15.0 M |
||
| ONL Therapeutics Inc | 021-384866 | Executive Officer | 26.8 M of 47.4 M |
||
| ONL Therapeutics Inc | 021-379321 | Executive Officer | 2.0 M of 2.0 M |
||
| ONL Therapeutics Inc | 021-347166 | Executive Officer | 3.0 M of 3.0 M |
||
| Armune Bioscience Inc | 021-278953 | Executive Officer | 0.5 M of 2.0 M |
||
| Armune Bioscience Inc | 021-232535 | Executive Officer | 9.7 M of 10.5 M |
||